- Home
- FNGR vs IPSC Comparison
FNGR vs IPSC Comparison
Compare FNGR & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNGR
- IPSC
- Stock Information
- Founded
- FNGR 2016
- IPSC 2019
- Country
- FNGR Singapore
- IPSC United States
- Employees
- FNGR N/A
- IPSC N/A
- Industry
- FNGR Computer Software: Prepackaged Software
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- FNGR Technology
- IPSC Health Care
- Exchange
- FNGR Nasdaq
- IPSC Nasdaq
- Market Cap
- FNGR 72.0M
- IPSC 58.1M
- IPO Year
- FNGR N/A
- IPSC 2021
- Fundamental
- Price
- FNGR $1.45
- IPSC $0.51
- Analyst Decision
- FNGR
- IPSC Strong Buy
- Analyst Count
- FNGR 0
- IPSC 5
- Target Price
- FNGR N/A
- IPSC $4.67
- AVG Volume (30 Days)
- FNGR 282.2K
- IPSC 461.7K
- Earning Date
- FNGR 01-14-2025
- IPSC 03-19-2025
- Dividend Yield
- FNGR N/A
- IPSC N/A
- EPS Growth
- FNGR N/A
- IPSC N/A
- EPS
- FNGR N/A
- IPSC N/A
- Revenue
- FNGR $33,570,107.00
- IPSC $6,589,000.00
- Revenue This Year
- FNGR $260.03
- IPSC N/A
- Revenue Next Year
- FNGR N/A
- IPSC N/A
- P/E Ratio
- FNGR N/A
- IPSC N/A
- Revenue Growth
- FNGR N/A
- IPSC 194.81
- 52 Week Low
- FNGR $1.03
- IPSC $0.51
- 52 Week High
- FNGR $3.96
- IPSC $4.43
- Technical
- Relative Strength Index (RSI)
- FNGR 52.62
- IPSC 30.01
- Support Level
- FNGR $1.55
- IPSC $0.54
- Resistance Level
- FNGR $1.83
- IPSC $0.59
- Average True Range (ATR)
- FNGR 0.14
- IPSC 0.05
- MACD
- FNGR 0.01
- IPSC 0.00
- Stochastic Oscillator
- FNGR 41.54
- IPSC 0.00
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.